PofoliaShared via Pofolia

iScience· 2026Q1

Intestinal microbiota-associated LysoPC(16:0) promotes endometriosis via PPARγ-mediated M2 macrophage polarization and IL-10 secretion

Na Li, Ming Yuan, Xueyang Jin, Xue Jiao et al.

Short summary

A gut microbiota metabolite, LysoPC(16:0), promotes endometriosis by driving M2 macrophage polarization and IL-10 secretion via the PPARγ pathway.

AI-generated from the title and abstract; the full text is not read.

Key points

  • LysoPC(16:0), a metabolite linked to gut microbiota shifts, promotes endometriosis progression in mice.
  • LysoPC(16:0) induces M2 macrophage polarization and IL-10 secretion via the PPARγ pathway.
  • Macrophage depletion blocks LysoPC(16:0)-driven lesion growth.
  • LysoPC(16:0)-stimulated macrophages promote endometrial stromal cell migration from endometriosis patients.

AI-generated from the title and abstract; the full text is not read.

Abstract

Both gut microbiota dysbiosis and altered pelvic immune microenvironment have been linked to endometriosis (EM), but the metabolites connecting the two remain undefined. Combining 16S rDNA sequencing with non-targeted metabolomics in a murine EM model, we found altered gut microbiota composition alongside a marked rise in peritoneal lysophosphatidylcholine (LysoPC(16:0)), linked to the microbiota shift by correlation analysis and fecal transplantation. LysoPC(16:0) promoted M2 macrophage polarization through peroxisome proliferator-activated receptor gamma (PPARγ), an effect observed in two mouse strains. Clodronate-mediated macrophage depletion blocked LysoPC(16:0)-driven lesion growth. LysoPC(16:0) further induced PPARγ-dependent IL-10 transcription, and IL-10 neutralization in vivo reduced lesion weight. Conditioned medium from LysoPC(16:0)-stimulated THP-1 macrophages promoted migration of primary endometrial stromal cells from patients with EM, an effect reversed by GW9662 or IL-10 neutralization. Together, these results outline a gut microbiota-LysoPC(16:0)-PPARγ-M2–IL-10 axis in EM pathogenesis, a mechanistic and therapeutic target for future clinical study.

The authors' abstract, as published at the source. iScience, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Reproductive Medicine

Reproductive MedicineMedicine